Author

Maura Betti

Observed names: M Betti, M. Betti

Observed institutions: Polyclinic Medical Center, Azienda Ospedaliera di Perugia

OpenAlex ID: A5027323451

The impact of chemotherapy-induced nausea and vomiting on health-related quality of life

2006 · Enzo Ballatori, Fausto Roila, et al. · Supportive Care in Cancer · 140

Chemotherapy with cisplatin and teniposide for cerebral metastases in non-small cell lung cancer

1998 · V Minotti, L Crino′, et al. · Lung Cancer · 81

Gemcitabine and cisplatin as induction chemotherapy for patients with unresectable Stage IIIA‐bulky N2 and Stage IIIB nonsmall cell lung carcinoma

2003 · Federico Cappuzzo, Giovanni Selvaggi, et al. · Cancer · 46

2007 · Enrichetta Corgna, Maura Betti, et al. · Critical Reviews in Oncology/Hematology · 38

A Double‐Blind Study Comparing Two Single‐Dose Regimens of Ketorolac with Diclofenac in Pain Due to Cancer

1998 · Vincenzo Minotti, Maura Betti, et al. · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · 29

Attitudes of Italian General Practitioners in the Treatment of Cancer Pain

1997 · Vincenzo Minotti, Maura Betti · Tumori Journal · 12

Adjuvant Systemic Therapies in Patients with Colorectal Cancer: An Audit on Clinical Practice in Italy

2005 · Drug Utilization Review Team in Oncology (DURTO), Fausto Roila, et al. · Tumori Journal · 5

Gemcitabine—Cisplatin chemotherapy followed by radiotherapy in locally advanced non-small cell lung cancer (nsclc): A phase II retrospective analysis

2000 · L Crinò, F De Marinis, et al. · Lung Cancer · 5

The impact of angiogenesis on the metastasis in resected patients with stage IIIA N2 non small cell lung cancer (NSCLC)

1994 · S. Darwish, G. Fontanini, et al. · Lung Cancer · 3

73 Chemotherapy with cisplatin and teniposide (VM26) for cerebral metastasis in non small cell lung cancer (NSCLC): A phase II study

1997 · V. Minotti, L. Crino, et al. · Lung Cancer · 1

9050 NSCLC in never smokers, a different disease – a single institution retrospective evaluation

2009 · V. Minotti, R. Chiari, et al. · European Journal of Cancer Supplements

6522 POSTER EGFR mutations and response to TKIs therapy in NSCLC patients pre-treated with chemotherapy

2007 · L. Crinó, V. Ludovini, et al. · European Journal of Cancer Supplements

P3-077: EGFR mutations and response to tyrosine kinase inhibitors therapy in NSCLC patients previously treated with chemotherapy

2007 · Lucio Crinó, Vienna Ludovini, et al. · Journal of Thoracic Oncology

Works count: 13

Citation count: 360

H-index: 6

I10-index: 6